
Postdoctoral fellow @university of Connecticut medical school 🇺🇲
Connecticut, USA
Joined August 2016
- Tweets37
- Following66
- Followers60
- Likes31
Ashok cheemala retweeted
Excited to share that my PhD research has been published in eLife! Grateful to @sanjeevtmc for his guidance, and to my co-authors, including @KakaniParik, for their invaluable contributions.
Excited to share our new eLife paper! Deepak Pant @DeepPant94 found that the YEATS2-GCDH axis regulates histone crotonylation, which drives the expression of the EMT-promoting gene SPARC in head and neck cancer. @iiserbhopal @ANRFIndia @ERPLab_IISERB elifesciences.org/articles/1…
Ashok cheemala retweeted
What if Alzheimer’s, ALS, and FTD start not in neurons—but in the blood vessels that protect them?
New research reveals blood-brain barrier breakdown as a possible first domino in neurodegeneration.
@CheemalaAshok @UConn
Ashok cheemala retweeted
Read the article here- buff.ly/L48wVLL
What if diseases like Alzheimer’s and ALS don’t start with damaged brain cells, but with the blood vessels that protect them? New research suggests the blood-brain barrier may break down first.
43
Ashok cheemala retweeted
New Research Reveals Blood-Brain Barrier Breakdown as a Silent Trigger of Dementia and ALS
Read more:
🔗scisoup.org/article/2025/new…
@MurphyLabUCONN @CheemalaAshok @SciSoup @ScienceAdvances @Ratnesh_thakur @SciComm_India
Ashok cheemala retweeted
A detailed post can be found at 1patrickmurphy at bsky social, with the next questions we hope to address with input and support from @vascularbiology @AHAScience @alzassociation @AlzResearchUK @AFTDHope and @NINDSfunding @cshlmeetings
Ashok cheemala retweeted
Congratulations to Ashok, an exceptionally talented scientist who would be a tremendous junior faculty hire. Thank you to our collaborators @jacksonlab, lab members including @omaruximab and as others not on this platform, including Riqiang Yan.
Ashok cheemala retweeted
Despite strong headwinds our work continues. @CheemalaAshok shows that even a single point mutation in TDP-43 leads to large defects in cell-cell junction and barrier, and that brain endothelial deletion disrupts the BBB and leads to FTD-like behavior science.org/doi/10.1126/scia…
InFocus - Endothelial Dysfunction in Health & Disease members.navbo.org/calendar-o…
40
Early career excellence in neurodegenerative research | Carney Institute for Brain Science | Brown University carney.brown.edu/news/2025-0…
41
Ashok cheemala retweeted
I'm happy to announce that our paper describing the first in human tissue application of inCITE-seq, to assess nuclear levels of RNA-binding proteins, and key regulators of the blood brain barrier (b-Catenin and NF-kB) is now available online nature.com/articles/s41593-0…
Ashok cheemala retweeted
In parallel work (Science Advances next month and bioRxiv here : biorxiv.org/content/10.1...) from @CheemalaAshok we show that targeted deletion of TDP-43 in brain ECs compromises the BBB, and leads to dysfunction of pathways disrupted in human capillaries with reduced TDP-43.
Ashok cheemala retweeted
Have you wondered if there is a role for the endothelium in regulating immune responses, beyond its function as a gatekeeper? Here, we molecularly define an immune transition of the endothelium required for chronic CD8 T cell responses in atherosclerosis biorxiv.org/content/10.1101/….
Ashok cheemala retweeted
Thanks @mattcampbelltcd and @DWWilliamsLab for organizing a wonderful Gordon conference on barriers of the CNS, and for giving talented students @CheemalaAshok and @omaruximab a chance to present their own work. We came away with a lot of exciting new ideas!
Ashok cheemala retweeted
Beautiful, another key contribution to understanding TDP-43 in ECs. Please also see our preprints biorxiv.org/content/10.1101/… and biorxiv.org/content/10.1101/… showing similar BBB loss in ECs with a partial loss of nuc. TDP-43 (disease mutation), and a TDP-43 loss in ECs in human disease.
Ashok cheemala retweeted
Led by postdoc @CheemalaAshok in biorxiv.org/cgi/content/shor…, we followed up on a CRISPR screen showing that the loss of TDP-43 increased TNF-mediated activation of endothelial cells, interesting b/c endothelial activation and BBB disruption is early in disease progression.
Ashok cheemala retweeted
New preprints from our lab! biorxiv.org/cgi/content/shor… and biorxiv.org/cgi/content/shor… which show that the RNA-binding protein TDP-43 is reduced in the endothelium in neurodegenerative diseases AD and ALS/FTD, and that this reduction can cause BBB disruption.
Ashok cheemala retweeted
Our first CSH Brain Barriers meeting was great! So much good advice. Thanks to @DAgalliu Rich Daneman @Britta_in_Bern for helpful comments, and @SiegenthalerLab for leading an excellent meeting. And congratulations to our own @CheemalaAshok on the poster prize. We’ll be back!
Ashok cheemala retweeted
I was honored to be a part of the CSHL Brain Barriers Meeting and to learn from so many brilliant minds. Big thanks to @SiegenthalerLab for organizing, and congratulations to @CheemalaAshok on the well-deserved prize! #CSHL #BBB
Our first CSH Brain Barriers meeting was great! So much good advice. Thanks to @DAgalliu Rich Daneman @Britta_in_Bern for helpful comments, and @SiegenthalerLab for leading an excellent meeting. And congratulations to our own @CheemalaAshok on the poster prize. We’ll be back!
Ashok cheemala retweeted
We are glad to share our latest work on the ERK1/2-EGR1-SRSF10 axis and alternative splicing in head and neck cancer. Congratulations to @Sandhya93845546. Thank you @India_Alliance @serbonline @DAEIndia @iiserbhopal.
New Research: ERK1/2-EGR1-SRSF10 Axis Mediated Alternative Splicing Plays a Critical Role in Head and Neck Cancer: Aberrant alternative splicing is recognized to promote cancer pathogenesis, but the underlying mechanism is yet to be clear.… frontiersin.org/articles/10.… #celldevbio
















